Ovarian carcinomas are responsible for 25% of female genital tract malignancies and responsible for over 50% of gynecological deaths. Being insidious in onset, they are usually diagnosed in stage 3 and 4 and so have highest case fatality rates. To assess the relative incidence of gynecological malignancies in postmenopausal women, and to know the age of peak incidence and stage at presentation which affects the outcome, we carried out this study. An institution based, analytic, observational study, was carried out at Department of Obstetrics and Gynecology, unit B, Khyber Teaching Hospital, Peshawar from 1/1/2001 to 31/12/2003. The data of postmenopausal patients presenting with gynecological malignancies was collected and analyzed. Detailed history and all measures included in disease identification, work up of cases, mode of presentation, staging and management, surgery and adjuvant therapy were taken into account. Also methods for correction of anemia, infections, haemodynamic stability and surgery, postoperative care and complications were assessed. The associated morbidity and mortality were also considered and results compiled. All patients with gynecological malignancy in younger/premenopausal age group were excluded. A total of 64 cases with gynecological cancer in postmenopausal age were assessed. 36(56.25%) patients presented with ovarian malignancy, the commonest. 80% were suffering from stage III and IV carcinomas. Peak incidence age was 55-65 years range. Second commonest malignancy was carcinoma of cervix, 36(20.3%). Majority of these (46.15%) presented at stage II. Only 2(15.38%) out of 13 presented at stage I. The peak incidence age range was 45-50 years. A total of 8(14.06%) patients presented with carcinoma endometrium/ body of uterus. 5(55.5%) out of 9 were stage l. Peak incidence age range was 60-65 years. Only 6(9.37%) cases had carcinoma vulva, with majority presenting at stage III, whereby peak incidence age was 70 years. Commonest histopathology diagnosis was ovarian cancer (65%) out of which 70% were serous cyst adeno carcinoma. All cases of Carcinoma cervix 40 (100%) were squaumons cell type. 7(77.7%) out of 9 cases of Carcinoma endometrium were adeno carcinomas. All cases of Carcinoma vulva were squamous cell type. We concluded that gynecological malignancies were a major contributor to morbidity and mortality in postmenopausal ladies. Ovarian cancer, the major killer tends to present late. Early screening, increased health awareness, quick diagnosis and treatment can prevent a lot of suffering.